MedPath

Effect of propolis and melatonin on clinical factors of patients in intensive care units

Phase 3
Conditions
Systemic Inflammatory Response Syndrome.
Systemic Inflammatory Response Syndrome of infectious origin without organ failure
R65.0
Registration Number
IRCT20181025041460N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

Age between 18-75 years
Admission to the intensive care unit with the criteria of systemic inflammatory response syndrome (primary sepsis)

Exclusion Criteria

failure to start enteral nutrition during the first 48 hours of admission
Patients with autoimmune disorders, cancer and advanced sepsis
Sensitivity to bee products or known food allergies
Patients with infection of the immunodeficiency virus, severe liver failure
Severe and active bleeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath